封面
市場調查報告書
商品編碼
1377394

患者註冊軟體市場 - 2018-2028 年全球產業規模、佔有率、趨勢、機會和預測,按註冊類型、軟體類型、最終用戶、地區和競爭細分

Patient Registry Software Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented by Type of Registry, by Type of Software, by End User, by region, and Competition

出版日期: | 出版商: TechSci Research | 英文 172 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2022 年,全球病患登記軟體市場價值為 16 億美元,預計在預測期內將出現令人印象深刻的成長,複合CAGR為 9.33%。病患登記軟體是一種專門的醫療保健技術解決方案,旨在收集、管理和分析有關患有特定醫療狀況、疾病或特徵的患者的全面和結構化資料。它作為醫療保健組織、研究機構和公共衛生機構的集中資料庫,用於維護患者病史、治療結果和其他相關資訊的詳細記錄。患者登記通常是針對特定疾病的,這意味著它們是專門為收集患有健康狀況的患者的資料而量身定做的。這些病症的範圍從糖尿病或心血管疾病等常見慢性疾病到罕見疾病或特定患者特徵(例如妊娠登記)。為了確保一致性和互通性,病患登記軟體通常遵循標準化資料格式、編碼系統(例如ICD-10、SNOMED CT)和醫學術語。標準化對於資料交換和分析至關重要。該軟體包括驗證規則和檢查,以確保輸入註冊表的資料準確並符合預先定義的標準。驗證有助於維持資料品質和可靠性。

糖尿病、心血管疾病、癌症和呼吸系統疾病等慢性病的盛行率不斷上升,推動了對患者登記軟體的需求。這些系統對於追蹤和管理慢性病患者至關重要。從按服務付費到基於價值的護理模式的轉變強調了患者治療結果和人口健康管理的重要性。病患登記軟體在衡量和提高醫療品質和效率方面發揮著至關重要的作用。政府的獎勵措施、法規和資金鼓勵醫療機構採用電子健康記錄 (EHR) 和病患登記軟體。美國的「有意義的使用」等措施旨在促進電子病歷的採用。患者登記對於進行流行病學研究以了解疾病模式、風險因素和公共衛生趨勢至關重要。病患參與和賦權已成為醫療保健服務的核心。病患登記軟體透過讓病患參與資料收集和決策來支援以病患為中心的照護。

主要市場促進因素

市場概況
預測期 2024-2028
2022 年市場規模 16億美元
2028 年市場規模 27.1億美元
2023-2028 年CAGR 9.33%
成長最快的細分市場 疾病登記處
最大的市場 北美洲

流行病學研究不斷發展

目錄

第 1 章:產品概述

  • 市場定義
  • 市場範圍
    • 涵蓋的市場
    • 研究年份
    • 主要市場區隔

第 2 章:研究方法

  • 研究目的
  • 基線方法
  • 主要產業夥伴
  • 主要協會和二手資料來源
  • 預測方法
  • 數據三角測量與驗證
  • 假設和限制

第 3 章:執行摘要

  • 市場概況
  • 主要市場細分概述
  • 主要市場參與者概述
  • 重點地區/國家概況
  • 市場促進因素、挑戰、趨勢概述

第 4 章:客戶之聲

第 5 章:全球病患登記軟體市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按註冊類型(疾病註冊、健康服務註冊和產品註冊)
    • 依軟體類型(獨立軟體和整合軟體)
    • 按最終用戶(醫院、政府組織和第三方管理員 (TPA)、製藥、生物技術和醫療器材公司等)
    • 按地區
    • 按公司分類 (2022)
  • 市場地圖

第 6 章:亞太地區病患登記軟體市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按註冊機構類型
    • 依軟體類型
    • 按最終用戶
    • 按國家/地區
  • 亞太地區:國家分析
    • 中國患者登記軟體
    • 印度病患登記軟體
    • 澳洲病患登記軟體
    • 日本病患登記軟體
    • 韓國病患登記軟體

第 7 章:歐洲病患登記軟體市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按註冊機構類型
    • 依軟體類型
    • 按最終用戶
    • 按國家/地區
  • 歐洲:國家分析
    • 法國
    • 德國
    • 西班牙
    • 義大利
    • 英國

第 8 章:北美病患登記軟體市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按註冊機構類型
    • 依軟體類型
    • 按最終用戶
    • 按國家/地區
  • 北美:國家分析
    • 美國
    • 墨西哥
    • 加拿大

第 9 章:南美洲病患登記軟體市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按註冊機構類型
    • 依軟體類型
    • 按最終用戶
    • 按國家/地區
  • 南美洲:國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章:中東和非洲病患登記軟體市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按註冊機構類型
    • 依軟體類型
    • 按最終用戶
    • 按國家/地區
  • MEA:國家分析
    • 南非病患登記軟體
    • 沙烏地阿拉伯病患登記軟體
    • 阿拉伯聯合大公國病患登記軟體

第 11 章:市場動態

  • 促進要素
  • 挑戰

第 12 章:市場趨勢與發展

  • 最近的發展
  • 產品發布
  • 併購

第 13 章:全球病患登記軟體市場:SWOT 分析

第 14 章:波特的五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 客戶的力量
  • 替代產品的威脅

第 15 章:大環境分析

第16章:競爭格局

  • 達西瑪軟體公司
    • Business Overview
    • Company Snapshot
    • Products & Services
    • Financials (In case of listed companies)
    • Recent Developments
    • SWOT Analysis
  • 菲格德公司
    • Business Overview
    • Company Snapshot
    • Products & Services
    • Financials (In case of listed companies)
    • Recent Developments
    • SWOT Analysis
  • 環球視覺科技有限公司
    • Business Overview
    • Company Snapshot
    • Products & Services
    • Financials (In case of listed companies)
    • Recent Developments
    • SWOT Analysis
  • 圖像趨勢公司
    • Business Overview
    • Company Snapshot
    • Products & Services
    • Financials (In case of listed companies)
    • Recent Developments
    • SWOT Analysis
  • IQVIA
    • Business Overview
    • Company Snapshot
    • Products & Services
    • Financials (In case of listed companies)
    • Recent Developments
    • SWOT Analysis
  • 有序數據公司
    • Business Overview
    • Company Snapshot
    • Products & Services
    • Financials (In case of listed companies)
    • Recent Developments
    • SWOT Analysis
  • 麥肯森公司
    • Business Overview
    • Company Snapshot
    • Products & Services
    • Financials (In case of listed companies)
    • Recent Developments
    • SWOT Analysis
  • 麥肯森公司
    • Business Overview
    • Company Snapshot
    • Products & Services
    • Financials (In case of listed companies)
    • Recent Developments
    • SWOT Analysis
  • 維洛斯公司
    • Business Overview
    • Company Snapshot
    • Products & Services
    • Financials (In case of listed companies)
    • Recent Developments
    • SWOT Analysis
  • 塞納公司
    • Business Overview
    • Company Snapshot
    • Products & Services
    • Financials (In case of listed companies)
    • Recent Developments
    • SWOT Analysis

第 17 章:策略建議

關於我們及免責聲明

簡介目錄
Product Code: 16848

Global Patient Registry Software Market has valued at USD 1.60 billion in 2022 and is anticipated to witness an impressive growth in the forecast period with a CAGR of 9.33%. Patient Registry Software is a specialized healthcare technology solution designed to collect, manage, and analyze comprehensive and structured data about patients with specific medical conditions, diseases, or characteristics. It serves as a centralized database for healthcare organizations, research institutions, and public health agencies to maintain detailed records of patients' medical histories, treatment outcomes, and other relevant information. Patient registries are often disease-specific, meaning they are tailored to gather data on patients with medical conditions. These conditions can range from common chronic diseases like diabetes or cardiovascular disorders to rare diseases or specific patient characteristics (e.g., pregnancy registries). To ensure consistency and interoperability, patient registry software often adheres to standardized data formats, coding systems (e.g., ICD-10, SNOMED CT), and medical terminology. Standardization is critical for data exchange and analysis. The software includes validation rules and checks to ensure that data entered the registry is accurate and adheres to predefined standards. Validation helps maintain data quality and reliability.

The increasing prevalence of chronic diseases like diabetes, cardiovascular diseases, cancer, and respiratory conditions has driven the demand for patient registry software. These systems are essential for tracking and managing patients with chronic illnesses. The shift from fee-for-service to value-based care models has emphasized the importance of patient outcomes and population health management. Patient registry software plays a vital role in measuring and improving healthcare quality and efficiency. Government incentives, regulations, and funding have encouraged healthcare organizations to adopt electronic health records (EHRs) and patient registry software. Initiatives like Meaningful Use in the United States aimed to promote EHR adoption. Patient registries are essential for conducting epidemiological studies to understand disease patterns, risk factors, and public health trends. Patient engagement and empowerment have become central to healthcare delivery. Patient registry software supports patient-centric care by involving patients in data collection and decision-making.

Key Market Drivers

Market Overview
Forecast Period2024-2028
Market Size 2022USD 1.60 Billion
Market Size 2028USD 2.71 Billion
CAGR 2023-20289.33%
Fastest Growing SegmentDisease Registries
Largest MarketNorth America

Growing Epidemiological Studies

Epidemiological studies are research efforts that aim to understand the distribution and determinants of diseases and health-related conditions within populations. Patient registry software plays a crucial role in conducting, managing, and analyzing these studies. Epidemiological studies require the systematic collection of data on a large scale. Patient registry software provides a structured and efficient way to collect, store, and manage data from diverse sources, including healthcare facilities, research institutions, and public health agencies. Epidemiological studies often involve continuous monitoring of diseases and health conditions within populations. Patient registry software allows for real-time data capture and surveillance, helping to identify disease trends, outbreaks, and patterns. Tracking the health status of individuals over time is a fundamental aspect of epidemiological research. Patient registry software enables researchers to follow patients' health journeys, record treatment outcomes, and assess the long-term impact of interventions. Disease-specific registries are a type of patient registry that focuses on conditions, such as cancer, diabetes, or rare diseases. These registries are invaluable for epidemiological studies targeting specific diseases.

Epidemiological studies often investigate the role of various risk factors (e.g., genetics, lifestyle, environmental factors) in disease development. Patient registry software helps collect and analyze data related to these risk factors, facilitating complex statistical analysis. Understanding the outcomes of diseases and interventions is crucial in epidemiology. Patient registry software allows for the assessment of treatment effectiveness, disease progression, and patient outcomes. Patient registry software aids in identifying eligible participants for clinical trials and research studies, streamlining the recruitment process, and ensuring that researchers can access a relevant patient pool. Epidemiological studies influence public health policies and interventions. Patient registry software provides the data needed to make evidence-based decisions and track the impact of public health programs. Researchers often collaborate across institutions and regions to conduct epidemiological studies. Patient registry software supports data sharing and collaboration among research teams, even when they are geographically dispersed. Patient registry software often adheres to standardized data collection and reporting protocols, ensuring consistency in data across multiple studies and facilitating data sharing among researchers. Many epidemiological studies are longitudinal, meaning they track individuals over an extended period. Patient registry software is designed to handle longitudinal data effectively. Pharmaceutical companies and healthcare organizations increasingly rely on patient registry data as real-world evidence to support drug development, regulatory submissions, and post-market surveillance. This factor will help in the development of Global Patient Registry Software Market.

Increasing Demand of Population Health Management

Population health management refers to the proactive and systematic approach of improving the health outcomes and well-being of a defined population. Patient registry software helps healthcare organizations identify at-risk populations based on various factors, such as age, chronic conditions, social determinants of health, and risk behaviors. This enables healthcare providers to prioritize interventions for those who need them the most. Patient registry software allows for risk stratification, which involves categorizing patients into risk groups based on their health status and needs. This helps in tailoring care plans and interventions to specific risk levels, optimizing resource allocation. Effective population health management requires seamless care coordination among different healthcare providers, specialists, and community resources. Patient registry software facilitates care coordination by centralizing patient data and enabling communication among care team members. Chronic diseases are a significant driver of healthcare costs and morbidity. Patient registry software assists in managing chronic conditions by tracking patients' progress, ensuring adherence to treatment plans, and providing timely interventions. Population health management aims to prevent diseases and complications before they occur. Patient registry software helps in identifying patients due for preventive screenings, vaccinations, and health assessments, leading to early detection and prevention of illnesses. Patient registry software can support health promotion initiatives by tracking patients' lifestyle behaviors, such as diet, exercise, and smoking status. Healthcare providers can use this information to educate and motivate patients to adopt healthier habits.

Engaging patients in their own care is a fundamental aspect of population health management. Patient registry software can enable patients to access their health records, set health goals, and communicate with their healthcare providers, fostering active participation in health management. Population health management relies on data to inform decision-making. Patient registry software provides healthcare organizations with comprehensive data analytics and reporting tools to monitor population health trends, evaluate interventions, and adjust strategies accordingly. Healthcare organizations often use patient registry software to measure and improve the quality of care provided to populations. It helps in tracking key quality indicators and benchmarking performance against established standards and best practices. By effectively managing population health, healthcare organizations can optimize resource allocation, reduce unnecessary healthcare utilization, and control costs. Patient registry software supports resource allocation by targeting interventions where they will have the most significant impact. The transition to value-based care models, which prioritize outcomes over volume of services, emphasizes the importance of population health management. Patient registry software is a valuable tool for demonstrating value by improving health outcomes and reducing costs. Healthcare providers and payers often enter risk-based contracts that incentivize better population health management. Patient registry software helps providers identify and manage the risks associated with these contracts. This factor will pace up the demand of Global Patient Registry Software Market.

Rising Chronic Disease Burden

Chronic diseases, also known as non-communicable diseases (NCDs), are characterized by their long duration and generally slow progression. These diseases include conditions like diabetes, cardiovascular diseases, cancer, chronic respiratory diseases, and more. Patient Registry Software is essential for managing the growing number of patients with chronic diseases. It allows healthcare providers to maintain detailed and up-to-date records of patients with these conditions. Chronic disease management often involves long-term monitoring of patients. Patient Registry Software provides a centralized platform for tracking patient progress, adherence to treatment plans, and the evolution of the disease over time. Patient registries enable early detection of chronic diseases, allowing healthcare providers to initiate interventions and treatment at earlier stages when they are more manageable and cost-effective. Patient Registry Software supports population health management by helping healthcare organizations identify individuals at risk of developing chronic diseases and targeting preventive measures to reduce the disease burden.

The software can generate customized care plans for patients with chronic diseases based on their specific medical history, risk factors, and individual needs, thus improving the quality of care delivered. Data collected through Patient Registry Software helps healthcare providers make informed decisions about treatment options, medication adjustments, and lifestyle modifications for chronic disease management. Healthcare organizations use Patient Registry Software to measure and improve the quality of care provided to patients with chronic diseases. This can include monitoring key performance indicators, adherence to clinical guidelines, and patient outcomes. As remote healthcare services and telehealth become more prevalent, Patient Registry Software can integrate with these technologies to monitor patients with chronic diseases remotely, reducing the need for frequent in-person visits. Patient Registry Software is invaluable for clinical research into chronic diseases. Researchers can use the data collected to identify trends, assess treatment efficacy, and contribute to the development of new therapies and interventions. Chronic diseases can consume a significant portion of healthcare resources. Patient Registry Software helps optimize resource allocation by identifying high-risk patients and ensuring they receive the appropriate level of care. Value-based care models, which focus on achieving positive outcomes and reducing costs, align with the management of chronic diseases. Patient Registry Software assists in demonstrating value through improved health outcomes and cost-effective care delivery. Engaging patients in managing their chronic conditions is essential for successful long-term care. Patient Registry Software can provide patients with access to their health data, educational resources, and tools for self-management. This factor will accelerate the demand of Global Patient Registry Software Market.

Key Market Challenges

Data Quality and Accuracy

Ensuring the reliability and precision of data within patient registries is crucial for their effectiveness in supporting healthcare research, clinical care, and public health initiatives. Human errors during data entry, such as typos or incorrect information, can lead to inaccuracies in patient records. Even minor mistakes can have significant implications for patient care and research. Missing or incomplete data fields within patient records can hinder the ability to derive meaningful insights from the registry. Incomplete data may result from oversight during data entry or limitations in data collection processes. Duplicate records for the same patient can distort statistics and analysis. Patient registry software should have mechanisms to detect and prevent duplicate entries. Inconsistencies in data format, terminology, or coding can make it challenging to perform accurate analyses and comparisons. Standardizing data entry and terminology is crucial for consistency. Ensuring that data entered the registry is valid and follows predefined rules and standards is essential. Without proper validation, inaccurate data may be included. Maintaining data security and privacy while ensuring data quality is a delicate balance. Stringent security measures may restrict data accessibility, potentially affecting data accuracy. The absence of clear data governance policies and procedures can lead to data quality issues. Establishing data governance frameworks helps maintain data accuracy and consistency.

Data Standardization

Data standardization refers to the process of establishing and adhering to consistent formats, coding systems, and terminology for collecting, storing, and sharing healthcare data within patient registries. Patient registry software often aggregates data from various healthcare providers, facilities, and systems. Each source may use different data formats, coding schemes, and terminologies, making it difficult to achieve uniformity. Incompatibility between different healthcare IT systems, including Electronic Health Records (EHRs) and laboratory systems, can hinder data standardization efforts. Integrating data from these systems into patient registries may require complex mapping and translation processes. Different healthcare organizations may collect data using varied data fields, which can result in inconsistent data entry and storage practices. Standardizing the required data fields across multiple sources is a challenge. Medical terminology can vary regionally and across healthcare specialties. Harmonizing terminology to ensure consistency in data representation can be complex, especially in international patient registries. Standardizing coding systems for diagnoses, procedures, medications, and other healthcare data is crucial. However, the use of different coding systems (e.g., ICD-10, CPT, SNOMED CT) by healthcare organizations can pose a challenge. Data may be collected through different data entry practices, including free text, drop-down menus, and checkboxes. Ensuring that data is consistently entered and recorded in a standardized format can be challenging. Healthcare standards and coding systems are subject to updates and revisions. Ensuring that patient registry software stays up to date with the latest standards and maintains backward compatibility can be a logistical challenge.

Key Market Trends

Increased Adoption of Cloud-Based Solutions

Cloud-based patient registry software can easily scale up or down based on the needs of healthcare organizations. This flexibility is crucial as patient data volumes can vary significantly. Cloud solutions often eliminate the need for extensive on-premises hardware and infrastructure, reducing capital expenditures. Healthcare organizations can pay for cloud services on a subscription or pay-as-you-go basis, aligning costs with actual usage. Cloud-based patient registry software allows authorized users to access patient data and registry functions from virtually anywhere with an internet connection. This is particularly valuable for remote healthcare settings and telehealth initiatives. Reputable cloud providers invest heavily in security measures, often exceeding what individual healthcare organizations can implement. These providers offer robust data encryption, access controls, and disaster recovery options to protect patient data. Cloud-based solutions typically offer automated data backup and recovery capabilities, reducing the risk of data loss due to hardware failures or disasters. Cloud-based patient registry software can facilitate data sharing and interoperability by providing standardized interfaces and APIs. This enables integration with other healthcare systems, including EHRs and laboratory systems. Cloud vendors provide ongoing support, updates, and maintenance for the software, reducing the burden on healthcare IT staff.

Segmental Insights

Type of Registry Insights

In 2022, the Global Patient Registry Software Market dominated by Disease Registries segment and is predicted to continue expanding over the coming years. Disease registries are designed to collect and manage comprehensive data related to specific diseases or medical conditions. Healthcare organizations and research institutions often prioritize the management of diseases with high prevalence, significant impact, or unique research requirements. Disease registries are crucial for conducting clinical research and trials related to specific diseases. They provide a structured platform for collecting patient data, tracking disease progression, evaluating treatment outcomes, and identifying potential research participants. Government agencies and public health organizations frequently establish disease registries to monitor and manage public health issues. These registries help track disease trends, outbreaks, and the effectiveness of public health interventions.

Type of Software Insights

In 2022, the Global Patient Registry Software Market largest share was held by standalone segment and is predicted to continue expanding over the coming years. Standalone patient registry software solutions offer independence from other healthcare systems, such as Electronic Health Records (EHRs). This independence can provide greater flexibility in customization and data management, making them appealing to healthcare organizations that want more control over their patient registry data. Many standalone patient registry software solutions are purpose-built for specific diseases, conditions, or research purposes. This specialization allows them to provide tailored features and capabilities, making them attractive to organizations with specialized needs. For research institutions and organizations conducting clinical trials, standalone patient registry software can be essential. It allows them to gather and analyse data specific to their research objectives, ensuring accuracy and relevance.

End User Insights

In 2022, the Global Patient Registry Software Market largest share was held by Government Organizations and Third-Party Administrators (TPAs) segment in the forecast period and is predicted to continue expanding over the coming years. Government organizations often have strict regulatory requirements for healthcare data management. They are responsible for overseeing and regulating healthcare services within their jurisdictions. Patient registry software helps them ensure compliance with data security and privacy regulations, such as HIPAA in the United States or GDPR in Europe. Government bodies often run public health programs and initiatives that require comprehensive data collection and analysis. Patient registry software is a valuable tool for managing data related to disease surveillance, public health interventions, and population health management. Government health agencies use patient registry software to monitor and respond to disease outbreaks, track vaccination rates, and identify regions or communities with specific healthcare needs.

Regional Insights

The North America region dominates the Global Patient Registry Software Market in 2022. North America, particularly the United States and Canada, boasts advanced healthcare infrastructure with a well-established network of hospitals, clinics, and healthcare providers. This infrastructure creates a robust demand for healthcare IT solutions, including patient registry software. North America, especially the United States, has stringent data privacy regulations such as the Health Insurance Portability and Accountability Act (HIPAA). These regulations require healthcare organizations to maintain comprehensive patient records securely, driving the adoption of patient registry software to meet compliance requirements. The region is home to many renowned medical research institutions, universities, and academic medical centers. These institutions often use patient registry software for clinical research, epidemiological studies, and outcomes analysis.

Key Market Players

Dacima Software Inc.

FIGmd Inc.

Global Vision Technologies Inc.

Image Trend Inc.

IQVIA

Ordinal Data, Inc.

McKensson Corporation

Syneos Health

Velos Inc.

Cerner Corporation

Report Scope:

In this report, the Global Patient Registry Software Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Patient Registry Software Market, By Type of Registry:

  • Disease Registries
  • Health Service Registries
  • Product Registries

Patient Registry Software Market, By Type of Software:

  • Stand-alone Software
  • Integrated Software

Patient Registry Software Market, By End User:

  • Hospitals
  • Government Organizations and Third-Party Administrators (TPAs)
  • Pharmaceutical, Biotechnology, and Medical Device Companies
  • Other

Global Patient Registry Software Market, By region:

  • North America
  • United States
  • Canada
  • Mexico
  • Asia-Pacific
  • China
  • India
  • South Korea
  • Australia
  • Japan
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Italy
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

  • Company Profiles: Detailed analysis of the major companies present in the Global Patient Registry Software Market.

Available Customizations:

  • Global Patient Registry Software Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Patient Registry Software Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type of Registry (Disease Registries, Health Service Registries, and Product Registries)
    • 5.2.2. By Type of Software (Stand-alone Software and Integrated Software)
    • 5.2.3. By End User (Hospitals, Government Organizations and Third-Party Administrators (TPAs), and Pharmaceutical, Biotechnology, and Medical Device Companies, and Other)
    • 5.2.4. By Region
    • 5.2.5. By Company (2022)
  • 5.3. Market Map

6. Asia Pacific Patient Registry Software Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type of Registry
    • 6.2.2. By Type of Software
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. Asia Pacific: Country Analysis
    • 6.3.1. China Patient Registry Software Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type of Registry
        • 6.3.1.2.2. By Type of Software
        • 6.3.1.2.3. By End User
    • 6.3.2. India Patient Registry Software Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type of Registry
        • 6.3.2.2.2. By Type of Software
        • 6.3.2.2.3. By End User
    • 6.3.3. Australia Patient Registry Software Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type of Registry
        • 6.3.3.2.2. By Type of Software
        • 6.3.3.2.3. By End User
    • 6.3.4. Japan Patient Registry Software Market Outlook
      • 6.3.4.1. Market Size & Forecast
        • 6.3.4.1.1. By Value
      • 6.3.4.2. Market Share & Forecast
        • 6.3.4.2.1. By Type of Registry
        • 6.3.4.2.2. By Type of Software
        • 6.3.4.2.3. By End User
    • 6.3.5. South Korea Patient Registry Software Market Outlook
      • 6.3.5.1. Market Size & Forecast
        • 6.3.5.1.1. By Value
      • 6.3.5.2. Market Share & Forecast
        • 6.3.5.2.1. By Type of Registry
        • 6.3.5.2.2. By Type of Software
        • 6.3.5.2.3. By End User

7. Europe Patient Registry Software Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type of Registry
    • 7.2.2. By Type of Software
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Patient Registry Software Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type of Registry
        • 7.3.1.2.2. By Type of Software
        • 7.3.1.2.3. By End User
    • 7.3.2. Germany Patient Registry Software Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type of Registry
        • 7.3.2.2.2. By Type of Software
        • 7.3.2.2.3. By End User
    • 7.3.3. Spain Patient Registry Software Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type of Registry
        • 7.3.3.2.2. By Type of Software
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Patient Registry Software Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type of Registry
        • 7.3.4.2.2. By Type of Software
        • 7.3.4.2.3. By End User
    • 7.3.5. United Kingdom Patient Registry Software Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type of Registry
        • 7.3.5.2.2. By Type of Software
        • 7.3.5.2.3. By End User

8. North America Patient Registry Software Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type of Registry
    • 8.2.2. By Type of Software
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. North America: Country Analysis
    • 8.3.1. United States Patient Registry Software Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type of Registry
        • 8.3.1.2.2. By Type of Software
        • 8.3.1.2.3. By End User
    • 8.3.2. Mexico Patient Registry Software Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type of Registry
        • 8.3.2.2.2. By Type of Software
        • 8.3.2.2.3. By End User
    • 8.3.3. Canada Patient Registry Software Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type of Registry
        • 8.3.3.2.2. By Type of Software
        • 8.3.3.2.3. By End User

9. South America Patient Registry Software Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type of Registry
    • 9.2.2. By Type of Software
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Patient Registry Software Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type of Registry
        • 9.3.1.2.2. By Type of Software
        • 9.3.1.2.3. By End User
    • 9.3.2. Argentina Patient Registry Software Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type of Registry
        • 9.3.2.2.2. By Type of Software
        • 9.3.2.2.3. By End User
    • 9.3.3. Colombia Patient Registry Software Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type of Registry
        • 9.3.3.2.2. By Type of Software
        • 9.3.3.2.3. By End User

10. Middle East and Africa Patient Registry Software Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type of Registry
    • 10.2.2. By Type of Software
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Patient Registry Software Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type of Registry
        • 10.3.1.2.2. By Type of Software
        • 10.3.1.2.3. By End User
    • 10.3.2. Saudi Arabia Patient Registry Software Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type of Registry
        • 10.3.2.2.2. By Type of Software
        • 10.3.2.2.3. By End User
    • 10.3.3. UAE Patient Registry Software Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type of Registry
        • 10.3.3.2.2. By Type of Software
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. Global Patient Registry software Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Product

15. PESTLE Analysis

16. Competitive Landscape

  • 16.1. Dacima Software Inc.
    • 16.1.1. Business Overview
    • 16.1.2. Company Snapshot
    • 16.1.3. Products & Services
    • 16.1.4. Financials (In case of listed companies)
    • 16.1.5. Recent Developments
    • 16.1.6. SWOT Analysis
  • 16.2. FIGmd Inc.
    • 16.2.1. Business Overview
    • 16.2.2. Company Snapshot
    • 16.2.3. Products & Services
    • 16.2.4. Financials (In case of listed companies)
    • 16.2.5. Recent Developments
    • 16.2.6. SWOT Analysis
  • 16.3. Global Vision Technologies Inc.
    • 16.3.1. Business Overview
    • 16.3.2. Company Snapshot
    • 16.3.3. Products & Services
    • 16.3.4. Financials (In case of listed companies)
    • 16.3.5. Recent Developments
    • 16.3.6. SWOT Analysis
  • 16.4. Image Trend Inc.
    • 16.4.1. Business Overview
    • 16.4.2. Company Snapshot
    • 16.4.3. Products & Services
    • 16.4.4. Financials (In case of listed companies)
    • 16.4.5. Recent Developments
    • 16.4.6. SWOT Analysis
  • 16.5. IQVIA
    • 16.5.1. Business Overview
    • 16.5.2. Company Snapshot
    • 16.5.3. Products & Services
    • 16.5.4. Financials (In case of listed companies)
    • 16.5.5. Recent Developments
    • 16.5.6. SWOT Analysis
  • 16.6. Ordinal Data, Inc.
    • 16.6.1. Business Overview
    • 16.6.2. Company Snapshot
    • 16.6.3. Products & Services
    • 16.6.4. Financials (In case of listed companies)
    • 16.6.5. Recent Developments
    • 16.6.6. SWOT Analysis
  • 16.7. McKensson Corporation
    • 16.7.1. Business Overview
    • 16.7.2. Company Snapshot
    • 16.7.3. Products & Services
    • 16.7.4. Financials (In case of listed companies)
    • 16.7.5. Recent Developments
    • 16.7.6. SWOT Analysis
  • 16.8. McKensson Corporation
    • 16.8.1. Business Overview
    • 16.8.2. Company Snapshot
    • 16.8.3. Products & Services
    • 16.8.4. Financials (In case of listed companies)
    • 16.8.5. Recent Developments
    • 16.8.6. SWOT Analysis
  • 16.9. Velos Inc.
    • 16.9.1. Business Overview
    • 16.9.2. Company Snapshot
    • 16.9.3. Products & Services
    • 16.9.4. Financials (In case of listed companies)
    • 16.9.5. Recent Developments
    • 16.9.6. SWOT Analysis
  • 16.10. Cerner Corporation
    • 16.10.1. Business Overview
    • 16.10.2. Company Snapshot
    • 16.10.3. Products & Services
    • 16.10.4. Financials (In case of listed companies)
    • 16.10.5. Recent Developments
    • 16.10.6. SWOT Analysis

17. Strategic Recommendations

About Us & Disclaimer